The 20 Best Desmoplastic Small Round Cell Tumor Doctors Near Me in Baltimore, MD

Dr. Meyer will serve as the lead medical oncologist for adult sarcoma patients, and will focus on building the Adult Sarcoma and Connective Tissue Oncology Program. In collaboration with pediatric oncologist David Loeb, M.D., Ph.D., and orthopaedic surgeon Kristy Weber, M.D., Meyer will bring novel therapies to the clinic for sarcoma patients. Meyer received his bachelors and masters degrees in cell and molecular biology from Stanford University. From there, he joined the Medical Scientist Training Program at Baylor College of Medicine and earned his medical degree followed by a doctorate in immunology. Meyer completed his residency at the University of Maryland and served as chief resident in medicine from 2004-2005. Afterward, he joined our fellowship program in medical oncology and has been working in the laboratory of Jonathan Powell, M.D., Ph.D., on projects relating to the characterization of molecular regulatory pathways involved in T-cell activation and energy. As a third-year fellow, Meyer served as the chief fellow for our Training Programs in Hematology and Medical Oncology and he received a Young Investigator Award from the American Society of Clinical Oncology in 2010. Dr. Meyer is rated as a Distinguished provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Ganglioneuroblastoma, and Bone Tumor. Dr. Meyer is board certified in American Board Of Internal Medicine.

Stéphanie Gaillard is a medical oncologist who specializes in the treatment of gynecologic malignancies. She recently joined the faculty of the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and is their Director of Gynecologic Cancer Trials. Dr. Gaillard earned her medical degree and doctoral degree in cancer biology from Duke University. Following medical school, she underwent residency training in Internal Medicine and fellowship training in Medical Oncology at the Johns Hopkins School of Medicine. Dr. Gaillard’s research focuses on the development of clinical trials aimed at improving outcomes by incorporating promising new biologic, targeted, and immune therapies into standard treatment regimens. Her translational research program focuses on understanding the immune environment associated with gynecologic cancers and mechanisms of resistance to current therapies. Dr. Gaillard is rated as a Distinguished provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Tissue Biopsy, and Salpingo-Oophorectomy. Dr. Gaillard is board certified in American Board Of Internal Medicine.

William Houck is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Houck is rated as an Advanced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 73 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Chronic B-Cell Leukemia (CBCL), and Richter Syndrome. Dr. Houck is board certified in American Board Of Internal Medicine.

William Burns, M.D., is an assistant professor of surgery at the Johns Hopkins University School of Medicine and a surgeon within the Division of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology at The Johns Hopkins Hospital. Prior to joining the faculty at Johns Hopkins, Dr. Burns served as an assistant professor of surgery at the University of Michigan, as well as an attending physician at the University of Michigan Health Systems and the VA Ann Arbor Healthcare System. Dr. Burns received his medical degree from Yale University School of Medicine and was awarded a research training fellowship by the Howard Hughes Medical Institute. He completed an internship and residency in general surgery at The Johns Hopkins Hospital followed by clinical fellowship training in complex general surgical oncology at The University of Texas MD Anderson Cancer Center. Additionally, he completed postgraduate research fellowships in the field of cancer immunotherapy and tumor immunology at the National Cancer Institute and the MD Anderson Cancer Center. Dr. Burns specializes in treating patients with tumors of the pancreas and gastrointestinal tract, sarcoma and melanoma. He is trained in traditional and minimally invasive surgical techniques. Furthermore, he works closely with colleagues in medical and radiation oncology to provide comprehensive cancer care. His research focuses on immune cell-tumor cell interactions to improve outcomes in patients with pancreatic cancer, cancer immunotherapy for solid tumors, the role of lymph node surgery in the treatment of cancer, and human biospecimen analysis to guide therapy in patients with cancer. He is a member of several professional societies, including the American College of Surgeons, Society of Surgical Oncology, Association of Academic Surgery, and Society of Immunotherapy for Cancer. Dr. Burns is rated as an Advanced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Familial Pancreatic Cancer, Familial Colorectal Cancer, Small Bowel Resection, and Pancreatectomy. Dr. Burns is board certified in American Board Of Surgery.

Dr. Christine Pratilas is a pediatric medical oncologist at the Sidney Kimmel Comprehensive Cancer Center and Associate Professor of Oncology, Pediatrics & Cellular and Molecular Medicine at the Johns Hopkins University School of Medicine. She joined the Hopkins pediatric sarcoma team in 2014. Dr. Pratilas received her undergraduate degree in Biology from Drew University in New Jersey and her medical degree from UMDNJ - Robert Wood Johnson Medical School (now Rutgers University), where she also completed her internship and residency from 1999 to 2002. From 2002 to 2005 she was a fellow in hematology and oncology in the Memorial Sloan Kettering Cancer Center (MSKCC) Department of Pediatrics, and in the Department of Pediatric Hematology and Oncology at New York Weill Cornell Medical Center. She was a postdoctoral research fellow in Dr. Neal Rosen’s Molecular Oncogenesis Laboratory at MSKCC. From 2006 to 2014 she was attending in Pediatric Oncology at MSKCC, specializing in developmental therapeutics & sarcoma. She has been the director of the pediatric sarcoma program at Hopkins since 2018. Dr. Pratilas focuses her research on cancer-associated pathways and signal transduction, which involves figuring out how a cell’s internal molecular pathways work, and how those pathways can be molecularly controlled. This knowledge is the basis for developing promising new molecularly targeted cancer therapies, which is the focus of Dr. Pratilas’s research. Among her important scientific contributions is advancing our understanding of how certain proteins that can be mutated in cancer, known as RAF kinases (specifically BRAF), affect a cancer cell’s behavior. The research in Dr. Pratilas' laboratory is focused on RAS signal transduction pathways, concentrating on pediatric sarcomas such as rhabdomyosarcoma and malignant peripheral nerve sheath tumors, in order to develop novel therapeutics for children with these tumors. Dr. Pratilas is rated as an Advanced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Adult Soft Tissue Sarcoma, and Osteotomy. Dr. Pratilas is board certified in American Board Of Pediatrics.

Dr. Rebecca Stone is an associate professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. Her area of clinical expertise is gynecologic cancers, including cervical, uterine, vulvar and ovarian cancer, as well as gestational trophoblastic disease. Dr. Stone is a highly skilled surgeon with expertise in laparoscopic and robotic surgery for gynecologic tumors. She also serves as director of the Gynecology Enhanced Recovery after Surgery initiative, an innovative, multidisciplinary program that improves recovery and healing time after major abdominal surgery, as well as minimizes health care costs for patients. Dr. Stone received her undergraduate degree in biology from the University of Virginia. She earned her medical degree from the University of Virginia School of Medicine, where she subsequently completed her residency in obstetrics and gynecology. Dr. Stone performed a four-year gynecologic oncology fellowship at the University of Texas MD Anderson Cancer Center. She also earned a master’s degree in cancer biology from the University of Texas in 2010. Prior to joining Johns Hopkins, Dr. Stone was an assistant professor at the University of Arkansas for Medical Sciences, where she was one of five gynecologic oncologists serving the entire state. Dr. Stone is internationally recognized for her research pertaining to early diagnosis and treatment of ovarian cancer. She is widely published in the field of gynecologic oncology, with first-author papers in the New England Journal of Medicine and Lancet Oncology, as well as over 40 co-authored manuscripts in peer-reviewed medical journals. She was honored with an award for one of the most influential papers published in the field of obstetrics and gynecology in 2012 and with an Ovarian Cancer Research Fund Grant for “Unplugging Ovarian Cancer from the Power of Platelets.” Dr. Stone strongly believes in a multidisciplinary team approach to gynecologic cancer care. She seeks to provide women with the most advanced and personalized treatment plans while best preserving quality of life. She enjoys working with community providers so that patients are comforted by receiving care close to home. Dr. Stone is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Oophorectomy. Dr. Stone is board certified in American Board Of Obstetrics And Gynecology.

Kimberly Levinson, M.D., is an associate professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. Her areas of clinical expertise include minimally invasive surgery with both robotic and single incision laparoscopy, ovarian cancer debulking, cervical cancer and dysplasia. Dr. Levinson received her undergraduate degree from Tufts University. She earned her M.D. from the Johns Hopkins University School of Medicine and her M.P.H. from the Johns Hopkins Bloomberg School of Public Health. She completed her medical residency at the Johns Hopkins University School of Medicine and performed a clinical fellowship in gynecologic oncology at Cleveland Clinic. Dr. Levinson has also completed international research at Preventive Oncology International in Peru and the School for International Training in Chile. Dr. Levinson joined the Johns Hopkins faculty in 2014. Her research interests include health care disparities in gynecologic tumors, cervical cancer prevention and treatment, and surgical innovation. She has published numerous manuscripts in gynecologic oncology involving these and other various research topics. Dr. Levinson is currently a principal investigator in the Specialized Program of Research Excellence (SPORE) in Cervical Cancer. In addition, she has a strong commitment to education, and she is the assistant director of the Johns Hopkins residency program and the associate director of the Gynecologic Oncology fellowship. Dr. Levinson is a member of the American College of Obstetricians and Gynecologists, the Society of Gynecologic Oncology, and the American Medical Association. Dr. Levinson was recognized with a Robert B. Hunt Award for Best Paper Published in the Journal of Minimally Invasive Gynecology in 2014. Dr. Levinson is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Testicular Yolk Sac Tumor, Ovarian Cancer, Hysterectomy, and Lymphadenectomy. Dr. Levinson is board certified in American Board Of Obstetrics And Gynecology.

James Stuart Ferriss is an associate professor in the Johns Hopkins Department of Gynecology and Obstetrics and director of the F.J. Montz Gynecologic Oncology Fellowship Program. He is an expert in the care of women with cancers of the uterus, cervix, vulva, vagina, fallopian tubes and ovaries. Dr. Ferriss is passionate about minimally invasive approaches to surgery and has extensive experience with robotic surgery. Dr. Ferriss received his undergraduate and medical degrees from Louisiana State University. He then completed his residency in obstetrics and gynecology at the University of Texas Southwestern Medical Center and his fellowship in gynecologic oncology at the University of Virginia. Prior to joining Johns Hopkins, Dr. Ferriss was associate professor in the departments of women’s health and oncology at the University of Texas at Austin Dell Medical School. Before that, he was assistant professor in the department of obstetrics, gynecology and reproductive sciences at Temple University in Philadelphia. Dr. Ferriss’ research is focused on innovations in surgical and clinical education. Dr. Ferriss serves on a variety of boards and is a member of the Society of Gyneocologic Oncology, Mid-Atlantic Gynecologic Oncology Society, American Society of Clinical Oncology, the American College of Surgeons and the American Congress of Obstetricians and Gynecologists. He has been recognized with several awards and honors, including being named a top doctor for outstanding patient care. Dr. Ferriss’ passion for getting to know each of his patients’ values and personal treatment goals and empowering them to be active participants in their treatment defines his approach to patient care. Dr. Ferriss has special interest in supporting his patients through the entire arc of their cancer care from diagnosis to surgery, chemotherapy, and survivorship and palliative care. Videos Dr. Stuart FerrissGynecologic Oncologist Contact for Research Inquiries 600 N. Wolfe St Phipps 281 Baltimore, MD 21287 Research Summary Dr. Ferriss’ research currently focuses on increasing the diversity of patients recruited to clinical trials by understanding the factors and circumstances that prevent some patients from participating. He is also focused on innovations in surgical and clinical education. Dr. Ferriss is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Ovarian Cancer, Oophorectomy, and Lymphadenectomy. Dr. Ferriss is board certified in American Board Of Obstetrics And Gynecology.

Dr. Daniel Laheru is a cancer specialist in Baltimore, caring for patients with pancreatic cancer, colorectal cancer and neuroendocrine cancers. Dr. Laheru serves as co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care at Johns Hopkins Medicine. Dr. Laheru received his undergraduate degree in chemistry from The University of Utah. He earned his M.D. at Baylor College of Medicine. He completed his residency at The University of Utah Hospital and Clinics and performed a fellowship in medical oncology at The Johns Hopkins University School of Medicine and The Johns Hopkins Oncology Center. Dr. Laheru joined the Johns Hopkins faculty in 2001. Dr. Laheru's research interests include pancreatic cancer and chemotherapy resistance in pancreatic cancer. With Elizabeth Jaffee, M.D., he developed a vaccine that supercharges the immune system and causes immune cells, which tend to be tolerant of cancer, to seek out and kill pancreatic cancer cells throughout the body. He has given numerous invited talks on pancreatic cancer and other cancers both nationally and internationally. He has authored over 200 papers focused on pancreatic cancer. Dr. Laheru serves as associate editor of Annals of Pancreatic Cancer. He has been recognized by the American Society of Clinical Oncology with the Young Investigator Award, by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Isaac and Catharine Hecht Scholar and has been elected to the Miller-Coulson Academy of Clinical Excellence. He is a member of the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Laheru is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Laheru is board certified in American Board Of Internal Medicine.

Colleen McCormick, M.D., M.P.H., is an assistant professor in the Department of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine in Baltimore. Her areas of clinical expertise include gynecologic oncology with a focus on cervical and endometrial cancers, complex cancer cases and surgery for gynecologic cancers. A Baltimore native, Dr. McCormick received her undergraduate degree from Earlham College in Richmond, Virginia. Her advanced degrees include a doctorate in medicine and a Master of Public Health from Johns Hopkins. Dr. McCormick completed her residency as well as the F.J. Montz Fellowship in Gynecologic Oncology at The Johns Hopkins Hospital. She has significant clinical experience, initially in Portland, Oregon, where she was the medical director at Legacy Gynecologic Oncology. She was most recently at the University of New Mexico before returning home to Johns Hopkins and Baltimore. Her research interests include clinical trial programs, focusing on increasing diversity and inclusion in clinical trials. Deeply invested in patient experience, she recently served as a patient safety officer at the University of New Mexico, and she has researched practitioner and patient perspectives regarding endometrial cancer care. She has additional training in palliative care and genetic counseling, and she strongly values being able to accompany patients through their entire cancer journey. Dr. McCormick is a published author and has been invited to lecture both regionally and nationally. Dr. Mccormick is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Malignant Mixed Mullerian Tumor, Ovarian Cancer, Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, and Bladder Reconstruction. Dr. Mccormick is board certified in American Board Of Obstetrics And Gynecology.

Panayotis Ledakis is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Ledakis is rated as a Distinguished provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 79 other conditions, according to our data. His clinical expertise encompasses Appendix Cancer, Desmoplastic Small Round Cell Tumor, Anemia, Colorectal Cancer, and Ureteroscopy.

Fong W. Liu, M.D., M.P.H., is an assistant professor at the Johns Hopkins University School of Medicine. Her clinical expertise includes gynecologic oncology and general gynecology and obstetrics. Dr. Liu earned her Doctor of Medicine degree from the University of Alabama. She completed her residency in obstetrics and gynecology at Beth Israel Deaconess Medical Center in Boston, Massachusetts. Dr. Liu then went on to complete her fellowship in gynecologic oncology at the University of California, Irvine. Prior to joining Johns Hopkins, Dr. Liu served as an instructor in the department of obstetrics and gynecology at Beth Israel Deaconess Medical Center. Dr. Liu is also a gynecologic oncologist at the Sandra and Malcolm Berman Cancer Institute at GBMC. Dr. Liu is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Endometrial Cancer, Oophorectomy, and Hernia Surgery. Dr. Liu is board certified in American Board Of Obstetrics And Gynecology.

Fabian Johnston is a Surgical Oncologist practicing medicine in Baltimore, Maryland. Dr. Johnston is rated as a Distinguished provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Stomach Cancer, Gastrointestinal Stromal Tumor, Pancreatectomy, and Splenectomy.

Ravin Garg is a Hematologist Oncology specialist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Garg is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Paget Disease of the Breast, Breast Cancer, and Thrombotic Thrombocytopenic Purpura. Dr. Garg is board certified in American Board Of Internal Medicine.

Vadim Gushchin is a General Surgeon practicing medicine in Baltimore, Maryland. Dr. Gushchin is rated as an Advanced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Pseudomyxoma Peritonei, Colorectal Cancer, Familial Colorectal Cancer, Ureteral Reconstruction, and Small Bowel Resection.

Armando Sardi is a General Surgeon practicing medicine in Baltimore, Maryland. Dr. Sardi is rated as an Advanced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Pseudomyxoma Peritonei, Colorectal Cancer, Familial Colorectal Cancer, Ureteroscopy, and Hernia Surgery.

Katherine Thornton is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Thornton is rated as an Advanced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Angiosarcoma, Synovial Sarcoma, and Bone Tumor.

Richard Mackey is a Surgical Oncologist and a General Surgeon practicing medicine in Towson, Maryland. Dr. Mackey is rated as a Distinguished provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Choledocholithiasis, Retroperitoneal Liposarcoma, Pancreatic Cancer, Hernia Surgery, and Pancreatectomy. Dr. Mackey is currently accepting new patients.

Richard Schraeder is a Hematologist and an Oncologist practicing medicine in Towson, Maryland. Dr. Schraeder is rated as a Distinguished provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 61 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Retroperitoneal Liposarcoma. Dr. Schraeder is currently accepting new patients.

Stephanie Wethington is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Wethington is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Cervical Cancer, Ovarian Cancer, Oophorectomy, and Hysterectomy.